Equities

Colgate-Palmolive (India) Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
COLPAL:NSI

Colgate-Palmolive (India) Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (INR)2,122.20
  • Today's Change-13.80 / -0.65%
  • Shares traded374.09k
  • 1 Year change-14.15%
  • Beta1.1500
Data delayed at least 15 minutes, as of Feb 13 2026 10:22 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Colgate-Palmolive (India) Limited is primarily focused on oral care and personal care in the Indian market. The Company manufactures and markets a range of oral care essentials under the Colgate brand, including toothpastes, toothpowder, toothbrushes, mouthwashes and rinses, and specialty products such as professional grade oral care products. Additionally, its Palmolive brand offers a specialized range of personal care products. Its products include Colgate Strong Teeth toothpaste with Arginine, Colgate MaxFresh toothpaste with Ultrafreeze technology, Colgate Active Salt toothpaste with superior efficacy, Colgate Zig Zag toothbrush with superior aesthetics & packaging, Colgate Super Junior Toothbrush, and Palmolive's three variants include (Forever Happy, Sweet Delight, Alluring Love). It collaborates through its distributor's network or otherwise with a network of diverse wholesalers, modern trade stores, e-commerce and other retailers to make their products available to customers.

  • Revenue in INR (TTM)59.02bn
  • Net income in INR13.27bn
  • Incorporated1937
  • Employees2.20k
  • Location
    Colgate-Palmolive (India) LtdColgate Research CentreMain Street, Hiranandani Gardens, PowaiMUMBAI 400076IndiaIND
  • Phone+91 2 267095050
  • Fax+91 2 225705088
  • Websitehttps://www.colgateinvestors.co.in/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Chicmax Cosmetic Co Ltd97.08bn11.86bn301.19bn2.46k25.389.4521.613.102.572.5721.056.911.992.8321.364,016,794.0025.5114.1641.2827.5274.7768.5012.799.411.46320.910.107236.0562.0818.7769.4265.688.01--
Lion Corp250.30bn16.36bn304.04bn7.65k18.381.579.831.2199.6899.681,525.161,166.550.8234.255.37--6.055.098.887.7345.9445.997.366.041.47--0.080734.132.223.5030.15-1.58-6.425.46
Proya Cosmetics Co Ltd143.01bn20.69bn378.37bn3.39k18.275.09--2.653.993.9927.5714.311.362.7336.893,214,578.0020.1617.4926.5923.6972.8968.1114.8313.512.69--0.135530.1721.0428.1130.0031.6312.8531.64
Procter & Gamble Hygiene & Health Care43.41bn8.59bn379.60bn421.0044.16--42.298.74264.78264.781,337.25--------103,105,200.00--------63.07--19.80----92.83----------------
Hengan International Group Co Ltd297.10bn29.69bn392.18bn23.00k12.961.409.111.322.252.2522.5220.890.51114.089.491,068,483.005.117.0910.0014.0931.8035.879.9913.320.989711.350.434766.07-4.620.1563-17.93-10.0711.56-8.42
Giant Biogene Holding Co Ltd80.19bn29.67bn415.40bn2.16k13.343.4513.595.182.512.516.799.710.6412.8818.453,937,032.0023.7426.1729.6647.5181.7583.6337.0443.514.65--0.000834.3257.1742.0842.0630.1516.52--
Unilever Indonesia Tbk PT171.87bn19.03bn472.12bn3.30k24.7919.5220.532.7592.79200.92838.70117.821.776.7317.959,682,771,000.0019.6224.7570.6778.0947.7648.7211.0712.290.568951.740.126--4.31-5.7621.78-13.164.50--
Colgate-Palmolive (India) Ltd59.02bn13.27bn577.21bn2.20k43.49--39.109.7848.8048.80217.04--------26,852,590.00--40.32--68.9469.7461.8822.4822.02--420.86--103.816.335.958.5511.973.4112.74
Shiseido Co Ltd575.21bn-24.12bn783.01bn27.91k--2.2041.301.36-101.83-101.832,427.551,503.640.74641.486.25---3.060.9664-4.391.4176.6073.60-4.101.240.9403--0.3422---2.081.04-276.21---9.58--
Data as of Feb 13 2026. Currency figures normalised to Colgate-Palmolive (India) Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

13.10%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 31 Jan 20269.22m3.39%
The Vanguard Group, Inc.as of 04 Feb 20265.13m1.89%
Life Insurance Corporation of India (Investment Portfolio)as of 31 Mar 20254.56m1.68%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 20254.06m1.49%
BlackRock Fund Advisorsas of 06 Feb 20263.39m1.25%
First Sentier Investors (Hong Kong) Ltd.as of 31 Oct 20252.53m0.93%
Goldman Sachs Asset Management LPas of 06 Feb 20262.03m0.75%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Dec 20251.86m0.69%
BlackRock Advisors (UK) Ltd.as of 06 Feb 20261.44m0.53%
First Sentier Investors (Singapore)as of 31 Oct 20251.40m0.52%
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.